- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Monday, July 18, 2016
The question of whether specific contraceptive methods, particularly the injectable progestogen-only method known as DMPA or Depo-Provera, affect women's risk of HIV is complex and, for the moment, unanswered. And the WHO has added to the complexit with a layer of completely preventable confusion.
This graphic was excerpted from AVAC Report 2016: Big Data, Real People.